ISSN:
1432-0428
Keywords:
Key words Baculovirus
;
Sf9 cells
;
recombinant
;
human
;
islet
;
glutamic acid decarboxylase
;
65 kDa
;
purification.
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary The enzyme l-glutamic acid decarboxylase is a major autoantigen of the beta cell. Autoantibodies against this enzyme are observed before the onset of insulin-dependent diabetes mellitus (IDDM) in man and may be of predictive value. There is evidence that this enzyme is involved in the development of autoimmune diabetes in animals. In order to facilitate the investigation of the role of l-glutamine acid decarboxylase in IDDM, we expressed the 65 kDa isoform of human islet l-glutamic acid decarboxylase in insect cells using a baculovirus-based vector. The material was expressed at high levels (up to 50 mg/l of cells). Partially purified metabolically labelled l-glutamic acid decarboxylase bound to immunoglobulins in the sera from 20 of 49 subjects with newly-diagnosed IDDM. The enzyme was isolated in high yields (up to 26 mg/l cell culture) with fully maintained enzymatic activity by either ion-exchange chromatography or immunoaffinity chromatography. Purified l-glutamic acid decarboxylase inhibited the binding of radioactive l-glutamic acid decarboxylase, prepared by in vitro translation of mRNA, to immunoglobulins in the sera of subjects with IDDM. Recombinant human islet l-glutamic acid decarboxylase, isolated from Sf9 cells, is a suitable material for the large scale investigation of the utility of this enzyme in the prediction and prevention of autoimmune diabetes. [Diabetologia (1995) 38: 14–23
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s001250050248
Permalink
